The left and right internal thoracic artery (LITA and RITA, respectively), a branch of the subclavian artery, is often used for reconstruction of coronary arteries. Long-term results of this treatment ...

CEREBROVASCULAR disease ranked third, after heart disease and cancer, as a cause of death in the United States in 1959. Almost 37,000 of these deaths occurred in persons between thirty-eight and sixty ...

Aberrant subclavian artery anomalies represent the most common congenital variant of the aortic arch, often manifesting as an unusual origin or course of the subclavian artery. Such anomalies may be ...

CSBG: Carotid subclavian bypass graft; PTA: Percutaneous transluminal angioplasty. The treatment of subclavian artery occlusive disease has evolved from surgery to percutaneous-based treatment ...

CEREBROVASCULAR insufficiency due to subclavian-artery occlusion is more frequent, more simply diagnosed and more easily treated than generally recognized. Only recently has attention been focused on ...

Unfortunately, we do not have any level I evidence on the ideal management of subclavian artery occlusive disease. There is an abundance of case reports and retrospective papers on both endovascular ...

Patients with aortic stenosis who undergo transcatheter aortic valve replacement via the subclavian and femoral arteries have equivalent clinical outcomes at 30 days and 1 year, according to a new ...

Iatrogenic aortic dissection (IAD) constitutes 1% to 5% of acute type A aortic dissection cases. IAD is found in approximately 0.01% of patients during diagnostic coronary angiography, 0.19% of ...

The electro-osmotically modulated hemodynamic across an artery with multiple stenosis is mathematically evaluated. The non-Newtonian behaviour of blood flow is tackled by utilizing Casson fluid model ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Medtronic, Inc. (NYSE: MDT) today announced it has received CE (Conformité Européenne) Mark for the Medtronic CoreValve® System to be delivered using direct aortic access. The Medtronic CoreValve ...